Here you can search a selected list of NGAL literature relevant for research purposes.
Use the filters to the left to choose from a number of relevant areas or product relation.
The results showed that urinary NGAL and clusterin levels were significantly elevated in dogs on days 1 and 3 after administration of gentamicin, respectively.Read more
Analysis of plasma and urine NGAL monomer and homodimer in 151 Severe sepsis patients.Read more
A sensitive urinary biomarker for acute kidney injury (AKI) was investigated in beagle dogs with nephrotoxicity induced by gentamicinRead more
Acute kidney injury (AKI) is a common and often fatal disorder in dogs. Urine neutrophil gelatinase-associated lipocalin (NGAL)/creatinine ratio is a sensitive and specific biomarker of AKI in ninety-four dogs.Read more
Neutrophil gelatinase-associated lipocalin (NGAL) is a promising biomarker in humans and dogs with kidney disease. This protein is expressed by many cells including renal tubular cells and neutrophils. The aim of this study was to evaluate the effect of urinary tract infection (UTI) on urinary NGAL (uNGAL) concentration in dogs.Read more
Acute kidney injury (AKI) is a common clinical problem that still lacks effective treatment. Phosphodiesterase-5 (PDE5) inhibitors possess anti-apoptotic and anti-oxidant properties, making it a promising therapy for ischemia-reperfusion (I/R) injury of various organs. The present study evaluated the early nephroprotective effects of Tadalafil, a PDE5 inhibitor, in an experimental model of renal I/R.Read more
AKI is common following liver transplantation and is associated with significant morbidity and mortality. Biomarkers of AKI have not been well established in this setting but are needed to help guide patient care and facilitate development of novel therapeutics.Read more
To assess the utility of neutrophil gelatinase-associated lipocalin (NGAL) in both urine and serum as a follow-up marker for the discrimination of prerenal acute kidney injury (AKI) from intrinsic AKI in critically ill pediatric patients with established AKI at the time of patient presentation.Read more
Urinary neutrophil gelatinase-associated lipocalin (NGAL) has emerged an early marker protein, predicative of acute kidney injury (AKI) in various clinical settings.Read more
Kidney transplantation from a large donor to a small recipient, as in pediatric transplantation, is associated with an increased risk of thrombosis and DGF.Read more
Sensitive and specific biomarkers for early tubulointerstitial injury are lacking.Read more
The molecular forms of NGAL is a hot topic amongst NGAL researches these days.Read more
Prerenal acute kidney injury (AKI) is thought to be a reversible loss of renal function without structural damage.Read more
Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.
To download as pdf please click hereRead more
The neutrophil gelatinase associated lipocalin (NGAL) has been identified as the most promising biomarker of acute kidney injury (AKI). This study was aimed to evaluate a NGAL immunoassay on Beckman Coulter AU 5822.Read more
An evaluation of the utility of urine and plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations as biomarkers of AKI during and after liver transplantation.Read more
Early urinary biomarkers are a useful means to determine graft injury. ET-1 and NGAL are more accurate in predicting the severity of ischemic injury compared with inflammatory markersRead more
The objective is to investigate circulating biomarkers of initial graft injury in a porcine kidney autotransplant model.Read more
The enduring kidney graft shortage has led to the increasing use of expanded-criteria donors as well as kidneys donated after cardiac death, triggering the revival of machine perfusion preservation.Read more
Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for acute kidney injury (AKI). The ultimate goal is for NGAL to enable clinicians to intervene as early as possible and to change the prognosis of AKI.
To download as pdf please click hereRead more
A study of Fenoldopam efficacy as a pretreatment to avoid AKI on cardiopulmonary bypass pediatric patients using NGAL for definition of AKI...Read more
Acute kidney injury (AKI) has a profound impact on the morbidity and mortality of patients.Read more
Monocyte chemoattractant protein 1 (MCP-1) mediates acute ischemic and toxic kidney injury, but whether this can be used as a biomarker of acute kidney injury (AKI) is unknown.Read more
Neutrophil gelatinase-associated lipocalin (NGAL), an iron-transporting protein rapidly accumulating in the kidney tubules and urine after nephrotoxic and ischemic insults...Read more
To test the sensitivity and specificity of a single measurement of urinary neutrophil gelatinase-associated lipocalin (NGAL) and other urinary proteins to detect acute kidney injury...Read more